CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Index trend and stocks in action August 01, 2019
Karan Dsij
/ Categories: Trending

Index trend and stocks in action August 01, 2019

The Nifty opened the session on a negative note and slipped tad below the 11,000 mark momentarily. However, Nifty recovered gradually from the lows of the day to end with modest gain. The Nifty added 0.26 per cent to close at 11,114. Even though Nifty closed in the marginally positive territory, it formed a lower low and lower high. After closing below the 200-DMA (11,148) on July 30, Nifty attempted a pullback, but the pullback was resisted at 200-DMA. As long as Nifty trades below the 200-DMA, there are chances of the index moving further down towards the 10,980 level. Going ahead, only faster retracement above the 200-DMA will boost the sentiments in the markets. Further, the index needs to form higher high-low and this would be the first sign of revival for the bulls.

Sun Pharmaceutical: Sun Pharmaceutical announced that one of its wholly-owned subsidiaries has filed an application for manufacturing and marketing authorisation of Tildrakizumab for moderate-to-severe psoriasis and psoriatic arthritis with the Pharmaceuticals and Medical Devices Agency (PMDA), Japan.

BOSCH: With a view to adjusting production to meet the demand for products and to avoid unnecessary buildup of inventory, the company proposes to suspend all manufacturing operations at the company's plant in Bidadi for three days from August 1 to 3, 2019.

ZEEL: The company has announced that Invesco Oppenheimer Developing Markets Fund has agreed to buy 11 per cent stake in ZEEL for a total consideration value of Rs 4,224 crore.

Unichem Laboratories: The United States Food and Drug Administration (USFDA) conducted inspection at the company's Goa formulation facility between July 22 to July 31, 2019. The inspection was a routine GMP surveillance and post approval inspection for its ANDAs submitted from this facility. At the end of the inspection, the facility received four observations, with no repeat observations and are mostly procedural in nature.

GMR Infrastructure: The meeting of board of directors of the company is scheduled on August 5 to consider and approve raising of funds to the tune of about Rs 27,300 crore via equity and debt.

Mindtree: Mindtree has joined Hyperledger to accelerate blockchain development.

Previous Article Markets may open in the red following negative global cues
Next Article DHFL divests stake in 2 AMC entities
Print
1299 Rate this article:
5.0
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR